EUVIMEDEUVIMED entdecken
Open Access

Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway

Junbing Zhang, Claire M Simpson, Jacqueline Berner, Harrison B Chong, Jiafeng Fang, Zehra Ordulu, Tommy Weiss-Sadan, Anthony P Possemato, Stefan Harry, Mariko Takahashi, Tzu-Yi Yang, Marianne Richter und 26 weitere

Cell · 2023-05 · 186 (11) · 2361-2379.e25

DOI: 10.1016/j.cell.2023.04.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2023-05. Verfasst von Junbing Zhang und 37 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA. Electronic address: jzhang75@mgh.harvard.edu. Hauptthemen laut MEDLINE: Antineoplastic Agents, Reactive Oxygen Species. Die Arbeit wurde bisher 151-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple anticancer drugs have been proposed to cause cell death, in part, by increasing the steady-state levels of cellular reactive oxygen species (ROS). However, for most of these drugs, exactly how the resultant ROS function and are sensed is poorly understood. It remains unclear which proteins the ROS modify and their roles in drug sensitivity/resistance. To answer these questions, we examined 11 anticancer drugs with an integrated proteogenomic approach identifying not only many unique targets but also shared ones-including ribosomal components, suggesting common mechanisms by which drugs regulate translation. We focus on CHK1 that we find is a nuclear H2O2 sensor that launches a cellular program to dampen ROS. CHK1 phosphorylates the mitochondrial DNA-binding protein SSBP1 to prevent its mitochondrial localization, which in turn decreases nuclear H2O2. Our results reveal a druggable nucleus-to-mitochondria ROS-sensing pathway-required to resolve nuclear H2O2 accumulation and mediate resistance to platinum-based agents in ovarian cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsReactive Oxygen SpeciesHydrogen PeroxideMitochondriaCell NucleusHumans

Stichwörter der Autor:innen

CHK1chemical proteomicschemoresistancemitochondrial translationnuclear ROSnucleus-to-mitochondria signaling

Substanzen

Antineoplastic AgentsHydrogen PeroxideReactive Oxygen Species

Autor:innen und Institutionen

  • Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA. Electronic address: jzhang75@mgh.harvard.edu.
  • Cell Signaling Technology, Inc., Danvers, MA, USA.
  • Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA.
  • Division of Cardiology, Harvard Medical School, Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Obstetrics and Gynecology, Vincent Center for Reproductive Biology, Massachusetts General Hospital, Boston, MA, USA; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, USA.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIDCR NIH HHS

Zitieren

APA

Zhang, J., Simpson, C. M., Berner, J., Chong, H. B., Fang, J., Ordulu, Z., Weiss-Sadan, T., Possemato, A. P., Harry, S., Takahashi, M., Yang, T. Y., Richter, M., Patel, H., Smith, A. E., Carlin, A. D., Hubertus de Groot, A. F., Wolf, K., Shi, L., Wei, T. Y., …, & Bar-Peled, L. (2023). Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway. Cell, 186(11), 2361-2379.e25. https://doi.org/10.1016/j.cell.2023.04.026

Vancouver

Zhang J, Simpson CM, Berner J, Chong HB, Fang J, Ordulu Z, et al. Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway. Cell. 2023;186(11):2361-2379.e25. doi:10.1016/j.cell.2023.04.026

BibTeX
@article{Zhang2023,
  author = {Zhang, Junbing and Simpson, Claire M and Berner, Jacqueline and Chong, Harrison B and Fang, Jiafeng and Ordulu, Zehra and Weiss-Sadan, Tommy and Possemato, Anthony P and Harry, Stefan and Takahashi, Mariko and Yang, Tzu-Yi and Richter, Marianne and Patel, Himani and Smith, Abby E and Carlin, Alexander D and Hubertus de Groot, Adriaan F and Wolf, Konstantin and Shi, Lei and Wei, Ting-Yu and Dürr, Benedikt R and Chen, Nicholas J and Vornbäumen, Tristan and Wichmann, Nina O and Mahamdeh, Mohammed S and Pooladanda, Venkatesh and Matoba, Yusuke and Kumar, Shaan and Kim, Eugene and Bouberhan, Sara and Oliva, Esther and Rueda, Bo R and Soberman, Roy J and Bardeesy, Nabeel and Liau, Brian B and Lawrence, Michael and Stokes, Matt P and Beausoleil, Sean A and Bar-Peled, Liron},
  title = {Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway},
  journal = {Cell},
  year = {2023},
  volume = {186},
  number = {11},
  pages = {2361--2379.e25},
  doi = {10.1016/j.cell.2023.04.026}
}
Kostenlos starten →